- Service Name
Open Medicine Foundation (OMF)
- Industry
Healthcare, Nonprofit, Medical Research, Chronic Illness Research
- Main Value Proposition
OMF provides hope and support for individuals affected by ME/CFS and Long COVID through innovative research and collaboration.
- Description
Open Medicine Foundation is a nonprofit organization dedicated to advancing research and treatment for ME/CFS and Long COVID. It aims to bring together world-renowned scientists to collaborate on understanding and curing these complex diseases.
- Key Features
Open collaborative research approach; Multisystem disease focus; Global network of research centers; Real-time communication of research findings
- Use Cases
OMF is most valuable for patients suffering from ME/CFS and Long COVID, healthcare professionals seeking to understand these diseases, and researchers looking for collaborative opportunities.
- Competitive advantages
Focus on collaborative, multidisciplinary research; Real-time sharing of research findings; Global partnerships with leading research institutions
- Strengths
OMF's strengths lie in its commitment to open collaboration, its focus on complex diseases, and its ability to mobilize a large network of researchers and resources.
- Positioning
OMF positions itself as a leader in open collaborative research for ME/CFS and Long COVID, emphasizing the need for a comprehensive understanding of these complex diseases.
- Audience
The target users include patients with ME/CFS and Long COVID, healthcare providers, and researchers in the field of chronic diseases.
- CTA
Donate Now
- Tags
ME/CFS
Long COVID
Research
Collaboration
- Tagline
Together, we can move ME/CFS & Long COVID research further, faster.
- Tone of Voice
Compassionate, informative, collaborative
- Differentiation
OMF uniquely combines a multisystem approach to research with open collaboration among leading scientists, which is not commonly found in traditional research settings.
- Brand Positioning
OMF is identified as a compassionate and innovative organization that prioritizes patient needs and scientific advancement.
- Founded
2012-01-01
- Founders
Linda Tannenbaum